“Relapse”的搜索结果，显示 181-190 项，共有 2731 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... relapsed/refractory multiple myeloma (RRMM). A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety and best dose of PRGN-3006 T Cells to treat relapsed/refractory Acute Myeloid Leukemia and High Risk ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... relapsed NSCLC. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma. Rochester, Minn ...

4. 神经母细胞瘤- 生存率- 妙佑医疗国际

   Relapse. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/relapse. Accessed July 18, 2025. Recurrence ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This trial may help doctors find out what effects, good and/or bad, regimen UH-3 has on patients with newly diagnosed DAWT and standard risk relapsed FHWT ( ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study to Evaluate APG2575 Combined with Novel Therapeutic Regimens To Treat Subjects with Relapsed or Refractory Multiple Myeloma and Immunoglobulin Light ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...